Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (UK)

Index « Auteurs » - entrée « Florent Grange »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Florent Goussard < Florent Grange < Florent Mazel  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
001134 (2015) Jean Jacques Grob [France] ; Mayur M. Amonkar [États-Unis] ; Boguslawa Karaszewska [Pologne] ; Jacob Schachter [Israël] ; Reinhard Dummer [Suisse] ; Andrzej Mackiewicz [Pologne] ; Daniil Stroyakovskiy [Russie] ; Kamil Drucis [Pologne] ; Florent Grange [France] ; Vanna Chiarion-Sileni [Italie] ; Piotr Rutkowski [Pologne] ; Mikhail Lichinitser [Russie] ; Evgeny Levchenko [Russie] ; Pascal Wolter [Belgique] ; Axel Hauschild [Allemagne] ; Georgina V. Long [Australie] ; Paul Nathan [Royaume-Uni] ; Antoni Ribas [États-Unis] ; Keith Flaherty [États-Unis] ; Peng Sun [États-Unis] ; Jeffrey J. Legos [États-Unis] ; Diane Opatt Mcdowell [États-Unis] ; Bijoyesh Mookerjee [États-Unis] ; Dirk Schadendorf [Allemagne] ; Caroline Robert [France]Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Administration, Oral
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
1Biomarkers, Tumor (genetics)
1DNA Mutational Analysis
1Disease Progression
1Disease-Free Survival
1Drug Administration Schedule
1Genetic Predisposition to Disease
1Humans
1Imidazoles (administration & dosage)
1Imidazoles (adverse effects)
1Imidazoles (therapeutic use)
1Indoles (administration & dosage)
1Indoles (adverse effects)
1Indoles (therapeutic use)
1Intention to Treat Analysis
1MAP Kinase Kinase Kinases (antagonists & inhibitors)
1MAP Kinase Kinase Kinases (metabolism)
1Melanoma (drug therapy)
1Melanoma (genetics)
1Melanoma (mortality)
1Melanoma (secondary)
1Mutation
1Oximes (administration & dosage)
1Oximes (adverse effects)
1Oximes (therapeutic use)
1Phenotype
1Prospective Studies
1Protein Kinase Inhibitors (administration & dosage)
1Protein Kinase Inhibitors (adverse effects)
1Protein Kinase Inhibitors (therapeutic use)
1Proto-Oncogene Proteins B-raf (antagonists & inhibitors)
1Proto-Oncogene Proteins B-raf (genetics)
1Pyridones (administration & dosage)
1Pyridones (adverse effects)
1Pyridones (therapeutic use)
1Pyrimidinones (administration & dosage)
1Pyrimidinones (adverse effects)
1Pyrimidinones (therapeutic use)
1Quality of Life
1Risk Factors
1Skin Neoplasms (drug therapy)
1Skin Neoplasms (genetics)
1Skin Neoplasms (mortality)
1Skin Neoplasms (pathology)
1Sulfonamides (administration & dosage)
1Sulfonamides (adverse effects)
1Sulfonamides (therapeutic use)
1Surveys and Questionnaires
1Time Factors
1Treatment Outcome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Florent Grange" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Florent Grange" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Florent Grange
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024